New study tests how a common sedative changes brain activity during surgery

NCT ID NCT07259460

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how the drug dexmedetomidine, given through a precise infusion pump, affects brain wave monitors and pain sensors in 60 adults undergoing general anesthesia with propofol and remifentanil. Researchers want to see if changes in dexmedetomidine levels alter the Patient State Index, EEG patterns, and the Analgesia Nociception Index. The goal is to improve how doctors monitor sedation and pain during surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dexmedetomidine

What this could lead to

If successful, this could help anesthesiologists better adjust sedation and pain control during surgery, potentially improving patient safety and recovery.

What could go wrong

This is a small, early-phase observational study with only 60 participants. It does not test a new treatment or cure, so results may not change clinical practice directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADJUVANTS, ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Treviso Regional Hospital

    RECRUITING

    Treviso, TV, 31100, Italy

    Contact Email: •••••@•••••